86 related articles for article (PubMed ID: 1656890)
1. [Expression of ras oncogene p21 in relation to prognostic factors of human breast cancer].
Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Ueno Y; Yamashita H; Nomura K; Ichiguchi O
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2271-5. PubMed ID: 1656890
[TBL] [Abstract][Full Text] [Related]
2. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.
Clair T; Miller WR; Cho-Chung YS
Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
7. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras Rb1 and p53 proteins in human breast cancer.
Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
Miao TJ; Wang Z; Sang N
Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
[TBL] [Abstract][Full Text] [Related]
11. Ha-ras oncogene product in human oral squamous cell carcinoma.
Oku N; Shimada K; Itoh H
Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
Horiguchi J; Iino Y; Takei H; Morishita Y
Jpn J Clin Oncol; 1995 Aug; 25(4):119-23. PubMed ID: 7666587
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
[TBL] [Abstract][Full Text] [Related]
14. Expression of ras p21 in mammary and extramammary Paget's disease.
Mori O; Hachisuka H; Nakano S; Sasai Y; Shiku H
Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
[TBL] [Abstract][Full Text] [Related]
15. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
16. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer.
Li M; Liu W; Zhu YF; Chen YL; Zhang BZ; Wang R
Acta Oncol; 2006; 45(8):1115-9. PubMed ID: 17118848
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
18. Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.
Scambia G; Catozzi L; Benedetti-Panici P; Ferrandina G; Battaglia F; Giovannini G; Distefano M; Pellizzola D; Piffanelli A; Mancuso S
Gynecol Oncol; 1993 Sep; 50(3):339-46. PubMed ID: 8406198
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb.
Ikeguchi M; Saito H; Katano K; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Int Surg; 1997; 82(2):170-4. PubMed ID: 9331847
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]